4cyo
From Proteopedia
(Difference between revisions)
Line 8: | Line 8: | ||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4cyo FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4cyo OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4cyo RCSB], [http://www.ebi.ac.uk/pdbsum/4cyo PDBsum]</span></td></tr> | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4cyo FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4cyo OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4cyo RCSB], [http://www.ebi.ac.uk/pdbsum/4cyo PDBsum]</span></td></tr> | ||
</table> | </table> | ||
+ | == Function == | ||
+ | [[http://www.uniprot.org/uniprot/Q4Q5S8_LEIMA Q4Q5S8_LEIMA]] Adds a myristoyl group to the N-terminal glycine residue of certain cellular proteins (By similarity). | ||
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
== Publication Abstract from PubMed == | == Publication Abstract from PubMed == | ||
Line 21: | Line 23: | ||
</StructureSection> | </StructureSection> | ||
[[Category: Glycylpeptide N-tetradecanoyltransferase]] | [[Category: Glycylpeptide N-tetradecanoyltransferase]] | ||
- | [[Category: Bell, A S | + | [[Category: Bell, A S]] |
- | [[Category: Brannigan, J A | + | [[Category: Brannigan, J A]] |
- | [[Category: Goncalves, V | + | [[Category: Goncalves, V]] |
- | [[Category: Hutton, J A | + | [[Category: Hutton, J A]] |
- | [[Category: Leatherbarrow, R J | + | [[Category: Leatherbarrow, R J]] |
- | [[Category: Paape, D | + | [[Category: Paape, D]] |
- | [[Category: Roberts, S M | + | [[Category: Roberts, S M]] |
- | [[Category: Smith, D F | + | [[Category: Smith, D F]] |
- | [[Category: Tate, E W | + | [[Category: Tate, E W]] |
- | [[Category: Waugh, T | + | [[Category: Waugh, T]] |
- | [[Category: Wilkinson, A J | + | [[Category: Wilkinson, A J]] |
[[Category: Drug design]] | [[Category: Drug design]] | ||
[[Category: Inhibitor]] | [[Category: Inhibitor]] | ||
[[Category: Myristoylation]] | [[Category: Myristoylation]] | ||
[[Category: Transferase]] | [[Category: Transferase]] |
Revision as of 16:14, 24 December 2014
Leishmania major N-myristoyltransferase in complex with a hybrid inhibitor (compound 21).
|